Altimmune, Inc. has grown revenue −79% a year over three years and −63% a year over five. Revenue growth, 3-year annual rate: −79% (Biotechnology median +17%). Revenue growth, 5-year rate: −63%, growth has slowed since the five-year average. Years of annual history on file: 16, FY2010 to FY2025, as filed.

ALTAltimmune, Inc.

Healthcare

$2.60-34% 1Y

$2.60

$2.5952 weeks$6.18

Is it growing?

Is ALT growing?

Altimmune, Inc. has grown revenue −79% a year over three years and −63% a year over five.

−79%

Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: −63%
Revenue growth, 5-year rate · −79% over three · growth has slowed since the five-year average
Years of annual history on file: 16
Years of annual history on file · FY2010 to FY2025, as filed

Details›